High- or low-dose preoperative ipilimumab plus nivolumab in stage III urothelial cancer: the phase 1B NABUCCO trial
Nature
Contact Us To Get Started!
Work with us – your premier oncology partner – to optimize cancer care for patients
Work with us – your premier oncology partner – to optimize cancer care for patients